Synthetic vectors for gene transfer: Current state and perspectives;Vecteurs synthetiques pour le transfert de genes : Etat actuel et perspectives

Annales de l'Institut Pasteur/Actualites

Volumn 10, Issue 3-4, 1999, Pages 301-312

  Vivien, Eric ^a   Oudrhiri, Noufissa ^a   Vigneron, Jean Pierre ^b   Hauchecorne, Michelle ^a   Ramasawmy, Rajen ^a   Riquier, Sandrine ^b   Toury, Renée ^a   Fabrega, Sylvie ^a   Navarro, Jean ^a   Lehn, Jean Marie ^b   Lehn, Pierre ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b Centre de Recherche Interdisciplinaire en Biologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALIPHATIC COMPOUND; CATION; CHOLESTEROL; DENDRIMER; LIPID; LIPOSOME; POLYETHYLENEIMINE; POLYMER; SYNTHETIC DNA; SYNTHETIC PEPTIDE;

BIOTECHNOLOGY; CELLULAR DISTRIBUTION; COMPLEX FORMATION; ENDOSOME; EXPRESSION VECTOR; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; LIGAND BINDING; PHYSICAL CHEMISTRY; REVIEW;

EID: 0033165650     PISSN: 09244204     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-4204(00)80002-5     Document Type: Article

References (105)

1. [1] Alton E.W., Middleton P.G., Caplen N.J., Smith S.N., Steel D.M., Munkonge F.M., Jeffery P.K., Geddes D.M., Hart S.L., Williamson R., Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice, Nat. Genet. 2 (1993) 135-142.
2. [2] Anderson W.F., Human gene therapy, Nature 392 (1998) 25-30.
3. [3] Behr J.P., Synthetic gene transfer vectors, Acc. Chem. Res. 26 (1993) 274-278.
4. [4] Behr J.P., Demeneix B., Loeffler J.P., Perez-Mutul J., Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA, Proc. Natl. Acad. Sci. USA 18 (1989) 6982-6986.
5. [5] Bond V.C., Wold B., Poly-L-ornithine-mediated transformation of mammalian cells, Mol. Cell Biol. 7 (1987) 2286-2293.
6. [6] Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., Behr J.P., A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine, Proc. Natl. Acad. Sci. USA 92 (1995) 7297-7301.
7. [7] Brown P.M., Silvius J.R., Stability and fusion of lipid vesicles containing head-group-modified analogues of phosphatidylethanolamine, Biochim. Biophys. Acta 980 (1989) 181-190.
8. [8] Buschle M., Cotten M., Kirlappos H., Mechtler K., Schaffner G., Zauner W., Birnstiel M.L., Wagner E., Receptor-mediated gene transfer into human T lymphocytes via binding of DNA/CD3 antibody particles to the CD3 T cell receptor complex, Hum. Gene Ther. 6 (1995) 753-761.
9. [9] Caplen N.J., Alton E.W., Middleton P.G., Dorin J.R., Stevenson B.J., Gao X., Durham S.R., Jeffery P.K., Hodson M.E., Coutelle C., Huang L., Porteous D. J., Williamson R., Geddes D.M., Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis, Nat. Med. 1 (1995) 39-46.
10. [10] Collas P., Husebye H., Alestrom P., The nuclear localization sequence of the SV40 T antigen promotes transgene uptake and expression in zebrafish embryo nuclei, Transgenic Res. 5 (1996) 451-458.
11. [11] Cotten M., Saltik M., Kursa M., Wagner E., Maass G., Birnstiel M.L., Psoralen treatment of adenovirus particles eliminates virus replication and transcription while maintaining the endosomolytic activity of the virus capsid, Virology 205 (1994) 254-261.
12. [12] Crook K., McLachlan G., Stevenson B.J., Porteous D.J., Plasmid DNA molecules complexed with cationic liposomes are protected from degradation by nucleases and shearing by aerosolisation, Gene Ther. 3 (1996) 834-839.
13. [13] Curiel D.T., Agarwal S., Wagner E., Cotten M., Adenovirus enhancement of transferrin-polylysine-mediated gene delivery, Proc. Natl. Acad. Sci. USA 88 (1991) 8850-8854.
14. [14] Dean D.A., Import of plasmid DNA into the nucleus is sequence specific, Exp. Cell Res. 230 (1997) 293-302.
15. [15] Demeneix B.A., Behr J.P., The proton sponge: a trick the viruses did not exploit, in: Felgner P.L., Heller M.J., Lehn P., Behr J.P., Szoka F.C.Jr. (éd.), Artificial self assembling systems for gene delivery, American Chemical Society, Washington, 1995, pp. 146-151.
16. [16] Densmore C.L., Giddings T.H., Waldrep J.C., Kinsey B., Knight V., Gene transfer by guanidinium cholesterol-dioleoyl-phosphatidylethanolamine liposome-DNA complexes in aerosol, J. Gene Med. (sous presse).
17. [17] Donnelly J.J., Ulmer J.B., Shiver J.W., Liu M.A., DNA vaccines, Annu. Rev. Immunol. 15 (1997) 617-648.
18. [18] Ellens H., Bentz J., Szoka F.C., Fusion of phosphatidylethanolamine-containing liposomes and mechanism of the L alpha-HII phase transition, Biochemistry 25 (1986) 4141-1147.
19. [19] Erbacher P., Bettinger T., Belguise-Valadier P., Zou S., Coll J.L., Behr J.P., Remy J.S., Transfection and physical properties of various saccharide, poly(ethylene glycol) and antibody-derivatized polyethyleneimines (PEI), J. Gene Med. 1 (1999) 210-222.
20. [20] Erbacher P., Roche A.C., Monsigny M., Midoux P., The reduction of the positive charges of polylysine by partial gluconoylation increases the transfection efficiency of polylysine/DNA complexes, Biochim. Biophys. Acta 1324 (1997) 27-36.
21. [21] Fajac I., Briand P., Monsigny M., Midoux P., Sugar-mediated uptake of glycosylated polylysines and gene transfer into normal and cystic fibrosis airway epithelial cells, Hum. Gene Ther. 10 (1999) 395-406.
22. [22] Felgner P.L., Ringold G.M., Cationic liposome-mediated transfection, Nature 337 (1989) 387-388.
23. [23] Felgner P.L., Gadek T.R., Holm M., Roman R., Chan H.W., Wenz M., Northrop J.P., Ringold G.M., Danielsen M., Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure, Proc. Natl. Acad. Sci. USA 84 (1987) 7413-7417.
24. [24] Felgner J.H., Kumar R., Sridhar C.N., Wheeler C.J., Tsai Y.J., Border R., Ramsey P., Martin M., Felgner P.L., Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations, J. Biol. Chem. 269 (1994) 2550-2561.
25. [25] Foster B.J., Kern J.A., HER2-targeted gene transfer, Hum. Gene Ther. 8 (1997) 719-727.
26. [26] Fraley R., Subramani S., Berg P., Papahadjopoulos D., Introduction of liposome-encapsulated SV40 DNA into cells, J. Biol. Chem. 255 (1980) 10431-10435.
27. [27] Friend D.S., Papahadjopoulos D., Debs R.J., Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes, Biochim. Biophys. Acta 1278 (1996) 41-50.
28. [28] Gao X., Huang L., A novel cationic liposome reagent for efficient transfection of mammalian cells, Biochem. Biophys. Res. Commun. 179 (1991) 280-285.
29. [29] Gao X., Huang L., Cationic liposome-mediated gene transfer, Gene Ther. 2 (1995) 710-722.
30. [30] Gao X., Huang L., Potentiation of cationic liposome-mediated gene delivery by polycations, Biochemistry 35 (1996) 1027-1036.
31. [31] Gershon H., Ghirlando R., Guttman S.B., Minsky A., Mode of formation and structural features of DNA-cationic liposome complexes used for transfection, Biochemistry 32 (1993) 7143-7151.
32. [32] Gill D.R., Southern K.W., Mofford K.A., Seddon T., Huang L., Sorgi F., Thomson A., MacVinish L.J., Ratcliff R., Bilton D., Lane D.J., Littlewood J.M., Webb A.K., Middleton P.G., Colledge W.H., Cuthbert A.W., Evans M.J., Higgins C.F., Hyde S.C., A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis, Gene Ther. 4 (1997) 199-209.
33. [33] Gottschalk S., Cristiano R.J., Smith L.C., Woo S.L., Folate receptor mediated DNA delivery into tumor cells: potosomal disruption results in enhanced gene expression, Gene Ther. 1 (1994) 185-191.
34. [34] Gottschalk S., Sparrow J.T., Hauer J., Mims M.P., Leland F.E., Woo S.L., Smith L.C., A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells, Gene Ther. 3 (1996) 48-57.
35. [35] Gruenert D.C., Gene correction with small DNA fragments, Current Research In Molecular Therapeutics 1 (1998) 607-613.
36. [36] Gustafsson J., Arvidson G., Karlsson G., Almgren M., Complexes between cationic liposomes and DNA visualized by cryo-TEM, Biochim. Biophys. Acta, 1235 (1995) 305-312.
37. [37] Guo L.S.S., Cationic liposome containing noncytotoxic phospholipid and cholesterol derivatives, J. Liposome Res. 3 (1993) 51-70.
38. [38] Haensler J., Szoka F.C.Jr., Polyamidoamine cascade polymers mediate efficient transfection of cells in culture, Bioconjug. Chem. 4 (1994) 372-379.
39. [39] Hart S.L., Harbottle R.P., Cooper R., Miller A., Williamson R., Coutelle C., Gene delivery and expression mediated by an integrin-binding peptide, Gene Ther. 2 (1995) 552-554.
40. [40] Huxley C., Mammalian artificial chromosomes: a new tool for gene therapy, Gene Ther. 1 (1994) 7-12.
41. [41] Hyde S.C., Gill D.R., Higgins C.F., Trezise A.E., MacVinish L.J., Cuthbert A.W., Ratcliff R., Evans M.J., Colledge W.H., Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy, Nature 362 (1993) 250-255.
42. [42] Jolly D., Viral vector systems for gene therapy, Cancer Gene Ther. 1 (1994) 51-64.
43. [43] Kichler A., Freulon I., Boutin U., Mayer R., Monsigny M., Midoux P., Glycofection in the presence of anionic fusogenic peptides: a study of the parameters affecting the peptide-mediated enhancement of the transfection efficiency, J. Gene Med. 1 (1999) 134-143.
44. [44] Kichler A., Zauner W., Morrison C., Wagner E., Ligand-polylysine mediated gene transfer, in: Felgner P.L., Heller M.J., Lehn P., Behr J.P., Szoka F.C.Jr. (éd.), Artificial self assembling systems for gene delivery, American Chemical Society, Washington, pp. 120-128.
45. [45] Kircheis R., Schüller S., Brunner S., Ogris M., Heider K.H., Zauner W., Wagner E., Polycation-based DNA complexes for tumor targeted gene delivery in vivo, J. Gene Med. 1 (1999) 111-120.
46. [46] Koltover I., Salditt T., Radler J.O., Safinya C.R., An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery, Science 281 (1998) 78-81.
47. [47] Kreiss P., Scherman D., Optimisation des plasmides et des vecteurs synthétiques pour la thérapie génique, Médecine/Sciences 15 (1999) 669-676.
48. [48] Kren B.T., Bandyopadhyay P., Steer C.J., In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides, Nat. Med. 4 (1998) 285-290.
49. [49] Kunzelmann K., Legendre J.Y., Knoell D.L., Escobar L.C., Xu Z., Gruenert D.C., Gene targeting of CFTR DNA in C.F. epithelial cells, Gene Ther. 3 (1996) 859-867.
50. [50] Labat-Moleur F., Steffan A.M., Brisson C., Perron H., Feugeas O., Furstenberger P., Oberling F., Brambilla E., Behr J.P., An electron microscopy study into the mechanism of gene transfer with lipopolyamines, Gene Ther. 3 (1996) 1010-1017.
51. [51] Lasic D.D., Strey H., Stuart M., Podgornik R., Frederik P.M., The structure of DNA-liposome complexes, J. Am. Chem. Soc. 119 (1997) 832-833.
52. [52] Ledley F.D., Pharmaceutical approach to somatic gene therapy, Pharm. Res. 13 (1996) 1595-1614.
53. [53] Ledley F.D., Nonviral gene therapy: the promise of genes as pharmaceutical products, Hum. Gene Ther. 6 (1995) 1129-1144.
54. [54] Legendre J.Y., Haensler J., Rémy J.S., Les vecteurs non viraux de la thérapie génique, Médecine/Sciences 12 (1996) 1334-1341.
55. [55] Lehn P., Fabrega S., Oudrhiri N., Navarro J., Gene delivery systems: bridging the gap between recombinant viruses and artificial vectors, Adv. Drug Deliv. Rev. 30 (1998) 5-11.
56. [56] Lesoon-Wood L.A., Kim W.H., Kleinman H.K., Weintraub B.D., Mixson A.J., Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice, Hum. Gene Ther. 6 (1995) 395-405.
57. [57] Leventis R., Silvius J.R., Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles, Biochim. Biophys. Acta 1023 (1990) 124-132.
58. [58] Liu Y., Liggitt D., Zhong W., Tu G., Gaensler K., Debs R., Cationic liposome-mediated intravenous gene delivery, J. Biol. Chem. 270 (1995) 24864-24870.
59. [59] Loeffler J.P., Barthel F., Feltz P., Behr J.P., Sassone-Corsi P., Feltz A., Lipopolyamine-mediated transfection allows gene expression studies in primary neuronal cells, J. Neurochem. 54 (1990) 1812-1815.
60. [60] Michael S.I., Curiel D.T., Strategies to achieve targeted gene delivery via the receptor-mediated endocytosis pathway, Gene. Ther. 1 (1994) 223-232.
61. [61] Miller A.D., Cationic liposomes for gene therapy, Angew. Chem. Int. Ed. 37 (1998) 1768-1785.
62. [62] Mir L.M., Bureau M.F., Rangara R., Schwartz B., Scherman D., Long-term, high level in vivo gene expression after electric pulse-mediated gene transfer into skeletal muscle, C. R. Acad. Sci. 321 (1998) 893-899.
63. [63] Monsigny M., Midoux P., Roche A.C., Perspectives ex vivo et in vivo pour la thérapie génique, de la transfection sélective à l'aide de complexes plasmide-polylysine ciblés, in: Kahn A. (éd.), Thérapie génique: l'ADN médicament, John Libbey, Paris, 1993, pp. 99-107.
64. [64] Moradpour D., Schauer J.I., Zurawski V.R.Jr., Wands J.R., Boutin R.H., Efficient gene transfer into mammalian cells with cholesteryl-spermidine Biochem. Biophys. Res. Commun. 221 (1996) 82-88.
65. [65] Mulligan R.C., The basic science of gene therapy, Science 260 (1993) 926-932.
66. [66] Nabel G.J., Gordon D., Bishop D.K., Nickoloff B.J., Yang Z.Y., Aruga A., Cameron M.J., Nabel E.G., Chang A.E., Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes, Proc. Natl. Acad. Sci. USA 193 (1996) 15388-15393.
67. [67] Nicolau C., Le Pape A., Soriano P., Fargette F., Juhel M.F., In vivo expression of rat insulin after intravenous administration of the liposome-entrapped gene for rat insulin I, Proc. Natl. Acad. Sci. USA 80 (1983) 1068-1072.
68. [68] Nicolau C., Sene C., Liposome-mediated DNA transfer in eukaryotic cells. Dependence of the transfer efficiency upon the type of liposomes used and the host cell cycle stage, Biochim. Biophys. Acta 721 (1982) 185-190.
69. [69] Oudrhiri N., Vigneron J.P., Hauchecorne M., Toury R., Lemoine A.I., Peuchmaur M., Navarro J., Lehn J.M., Lehn P., Guanidinium-cholesterol cationic lipids: novel reagents for gene transfection and prospectives for gene therapy, Biogenic amines 14 (1998) 537-552.
70. [70] Oudrhiri N., Vigneron J.P., Peuchmaur M., Leclerc T., Lehn J.M., Lehn P., Gene transfer by guanidinium-cholesterol cationic lipids into airway epithelial cells in vitro and in vivo, Proc. Natl. Acad. Sci. USA 94 (1997) 1651-1656.
71. [71] Pitard B., Aguerre O., Airiau M., Lachages A.M., Boukhnikachvili T., Byk G., Dubertret C., Herviou C., Scherman D., Mayaux J.F., Crouzet J., Virus-sized self-assembling lamellar complexes between plasmid DNA and cationic micelles promote gene transfer, Proc. Natl. Acad. Sci. USA 94 (1997) 14412-14417.
72. [72] Pitard B., Oudrhiri N., Vigneron J.P., Hauchecorne M., Aguerre O., Toury R., Airiau M., Ramasawmy R., Scherman D., Crouzet J., Lehn J.M., Lehn P., Structural characteristics of supramolecular assemblies formed by guanidinium-cholesterol reagents for gene transfection, Proc. Natl. Acad. Sci. USA 96 (1999) 2621-2626.
73. [73] Plank C., Mechtler K., Szoka F.C.Jr., Wagner E., Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery, Hum. Gene Ther. 7 (1996) 1437-1446.
74. [74] Plank C., Oberhauser B., Mechtler K., Koch C., Wagner E., The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems, J. Biol. Chem. 269 (1994) 12918-12924.
75. [75] Plank C., Zatloukal K., Cotten M., Mechtler K., Wagner E., Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand, Bioconjug. Chem. 3 (1992) 533-539.
76. [76] Pollard H., Remy J.S., Loussouarn G., Demolombe S., Behr J.P., Escande D., Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells, J. Biol. Chem. 273 (1998) 7507-7511.
77. [77] Porteous D.J., Dorin J.R., McLachlan G., Davidson-Smith H., Davidson H., Stevenson B.J., Carothers A.D., Wallace W.A., Moralee S., Hoenes C., Kallmeyer G., Michaelis U., Naujoks K., Ho L.P., Samways J.M., Imrie M., Greening A.P., Innes J.A., Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis, Gene Ther. 4 (1997) 210-218.
78. [78] Radler J.O., Koltover I., Salditt T., Safinya C.R., Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes, Science 275 (1997) 810-814.
79. [79] Rose J.K., Buonocore L., Whitt M.A., A new cationic liposome reagent mediating nearly quantitative transfection of animal cells, Biotechniques 10 (1991) 520-525.
80. [80] Ross G.F., Morris R.E., Ciraolo G., Huelsman K., Bruno M., Whitsett J.A., Baatz J.E., Korfhagen T.R., Surfactant protein A - polylysine conjugates for delivery of DNA to airway cells in culture, Hum. Gene Ther. 6 (1995) 31-40.
81. [81] Rubin J., Charboneau J.W., Reading C., Kovach J.S., Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer, Hum. Gene Ther. 5 (1994) 1385-1399.
82. [82] San H., Yang Z.Y., Pompili V.J., Jaffe M.L., Plautz G.E., Xu L., Felgner J.H., Wheeler C.J., Felgner P.L., Huang L., Nabel E.G., Safety and short-term toxicity of a novel cationic lipid formulation for human gene therapy, Hum. Gene Ther. 4 (1993) 781-788.
83. [83] Seung L.P., Mauceri H.J., Beckett M.A., Hallahan D.E., Hellman S, Weichselbaum R.R., Genetic radiotherapy overcomes tumor resistance to cytotoxic agents, Cancer Res. 55 (1995) 5561-5655.
84. [84] Stamatatos L., Leventis R., Zuckermann M.J., Silvius J.R., Interactions of cationic lipid vesicles with negatively charged phospholipid vesicles and biological membranes, Biochemistry 27 (1988) 3917-3925.
85. [85] Sternberg B., Sorgi F.L., Huang L., New structures in complex formation between DNA and cationic liposomes visualized by freeze-fracture electron microscopy, FEBS Lett. 356 (1994) 361-366.
86. [86] Stewart M.J., Plautz G.E., Del Buono L., Yang Z.Y., Xu L., Gao X., Huang L., Nabel E.G., Nabel G.J., Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice, Hum. Gene Ther. 3 (1992) 267-275.
87. [87] Stribling R., Brunette E., Liggitt D., Gaensler K., Debs R., Aerosol gene delivery in vivo, Proc. Natl. Acad. Sci. USA 89 (1992) 11277-11281.
88. [88] Tang M.X., Redemann C.T., Szoka F.C.Jr., In vitro gene delivery by degraded polyamidoamine dendrimers, Bioconjug. Chem. 7 (1996) 703-714.
89. [89] Thierry A.R., Lunardi-Iskandar Y., Bryant J.L., Rabinovich P., Gallo R.C., Mahan L.C., Systemic gene therapy: biodistribution and long-term expression of a transgene in mice, Proc. Natl. Acad. Sci. USA 92 (1995) 9742-9746.
90. [90] Trubetskoy V.S., Torchilin V.P., Kennel S.J., Huang L., Use of N-terminal modified poly(L-lysine)-antibody conjugate as a carrier for targeted gene delivery in mouse lung endothelial cells, Bioconjug. Chem. 3 (1992) 323-327.
91. [91] Vigneron J.P., Oudrhiri N., Fauquet M., Vergely L., Bradley J.C., Basseville M., Lehn P., Lehn J.M., Guanidinium-cholesterol cationic lipids: efficient vectors for the transfection of eukaryotic cells, Proc. Natl. Acad. Sci. USA 93 (1996) 9682-9686.
92. [92] Wagner E., Receptor mediated delivery of plasmid DNA, Biogenic Amines 14 (1998) 519-536.
93. [93] Wagner E., Zenke M., Cotten M., Beug H., Birnstiel M.L., Transferrin-polycation conjugates as carriers for DNA uptake into cells, Proc. Natl. Acad. Sci. USA 87 (1990) 3410-3414.
94. [94] Wasan E.K., Reimer D.L., Bally M.B., Plasmid DNA is protected against ultrasonic cavitation-induced damage when complexed to cationic liposomes, J. Pharm. Sci. 85 (1996) 427-433.
95. [95] Wheeler C.J., Felgner P.L., Tsai Y.J., Marshall J., Sukhu L., Doh S.G., Hartikka J., Nietupski J., Manthorpe M., Nichols M., Plewe M., Liang X., Norman J., Smith A., Cheng S.H., A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung, Proc. Natl. Acad. Sci. USA 93 (1996) 11454-11459.
96. [96] Wu G.Y., Wu C.H., Receptor-mediated gene delivery and expression in vivo, J. Biol. Chem. 263 (1988) 14621-14624.
97. [97] Wu G.Y., Wu C.H., Receptor-mediated in vitro gene transformation by a soluble DNA carrier system, J. Biol. Chem. 262 (1987) 4429-4432.
98. [98] Xu Y., Szoka F.C.Jr., Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection, Biochemistry 35 (1996) 5616-5623.
99. [99] Yin W., Cheng P.W., Lectin conjugate-directed gene transfer to airway epithelial cells, Biochem. Biophys. Res. Commun. 205 (1994) 826-833.
100. [100] Yoon K., Cole-Strauss A., Kmiec E.B., Targeted gene correction of episomal DNA in mammalian cells mediated by a chimeric RNA.DNA oligonucleotide, Proc. Natl. Acad. Sci. USA 93 (1996) 2071-2076.
101. [101] Zabner J., Fasbender A.J., Moninger T., Poellinger K.A., Welsh M.J., Cellular and molecular barriers to gene transfer by a cationic lipid, J. Biol. Chem. 270 (1995) 18997-19007.
102. [102] Zanta M.A., Belguise-Valladier P., Behr J.P., Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus, Proc. Natl. Acad. Sci. USA 96 (1999) 91-96.
103. [103] Zelphati O., Szoka F.C.Jr., Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids, Pharm. Res. 13 (1996) 1367-1372.
104. [104] Zelphati O., Szoka F.C.Jr., Mechanism of oligonucleotide release from cationic liposomes, Proc. Natl. Acad. Sci. USA 93 (1996) 11493-11498.
105. [105] Zhu N., Liggitt D., Liu Y., Debs R., Systemic gene expression after intravenous DNA delivery into adult mice, Science 261 (1993) 209-211.